Citadel Advisors’s Finch Therapeutics Group, Inc. Common Stock FNCH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-826	Closed	-$70K	–	7039
2022 Q2	$70K	Sell	826 -1,165	-59%	-$98.7K	﹤0.01%	5412
2022 Q1	$300K	Sell	1,991 -586	-23%	-$88.3K	﹤0.01%	4940
2021 Q4	$771K	Buy	+2,577	New	+$771K	﹤0.01%	4127